Page 22 - Mobility Management, March 2017
P. 22

ATP
tify in a spreadsheet. P
drug lowered cholesterol it’s tough to prove that
consumer fre
source
“A
Effo
CRT o
ea
Here’s
Uniqu
First of a therapists,
te
2
ch
2
wha
ll,
A
Se
e of press
s ask, “Does complex rehab
t they said.
e
S
now
yste
ries
mom who takes
ure i
rts to justify CRT take many forms, f
zips
A
m”
dad who
njuries
tion papers to academic research (see the Functional Mobility Assessment [FMA] sidebar). In light of this push to measure
utco
mes,
we ask
m surable, evidence-based outcomes t when choosing seating and mobility strate
ed clinici
class in a
her powe
t-grader who mastered her new head sses are life changing. They are also har
harmaceuti
we work for Kaiser. It’s a unique system. As we do High Mobility (CRT) clinics with a
nology supplier], s
march 2017 | mobilitymanagement
ubm
cal c
in x number of trial pa a custom-fit wheelchai
us
. Thus,
es
technology
ans and AT
it the clinical report an
n ultra
r chair
seat
ompan
fu
light
to
elevation
nding and referral
ro
Ps
(CRT)
m
chair with
the office and
array. d to
ies report that a
rticipants, but r cushion kept a
to cook
work?”
RESNA posi-
: How critical
o your decision making gies and equipment?
E
quan-
DME
n RTS [rehab
d approve (as
are
vidence &
You have so many
A grad student who power assist.
weight shifts every hour. dinner. A firs
Such succe
complex
re
hab technology success stories.
to
Outcomes
funders)
co-pay funders
w
le C
e are
power
support ou
wheelchair device
able
for the clin decisions.
imp
Mo
the recommend
somewhat a “
Even thou
power
assist.
assist.
We’ve u
re
to justify CRT f
new
or
m
sed RE
ortant and cri
r rec
such
gh w
As clin
ical decis
therapists comi
or
Will Evidence-Based
Practi
SNA
tical
end
ed C
as MediCal/Me
closed” system.
e are first-level r
vel reviewers who look at what is being approved and RT. For example, most funding will not cover seat ele
icians,
position
ce
Measures
Complex
Su
ommendations for adding these
s and recently wheelchair
, evidence-based outcomes support o
ions
to
us
we’ve ma
easurable, evidence-based outco
enable
ers to e
ng into our
s
ev
we document
items would benefit the patient based on medical reasons such as transfers for seat elevators and shoulder pain and arthritis for
papers
&
dicaid,
iewers,
de rather
therapists,
for t
nhance their lives
technology available and to be as independent as possible. Perhaps evidence-based outcome studies would be helpful for
world in
O
ccess?
By Laurie Watanabe
RT. There are
ilt
viewed the application of seat elevating users. As clinicians for an HMO, measur-
ur
ut
times wh
and
recom
co
Drive
Rehab
but for the most part,
there are often next-
functional reasons these
recli
than influenc
me studies are
pr
mes
ere there
[deny] vators an
ne to
features to po
mendations
oviders and funders
making dec
with
e our
the best
isions for
mobility
mgmt.com
are
wer
d
GEARS IMAGE: ISTOCKPHOTO.COM/NONGKRAN_CH
sf
   20   21   22   23   24